Sexually transmitted infections

The CDC just released its annual STD surveillance report. Are you caught up on the latest trends? Try your hand at these 7 questions to find out.

Details on educational gaps, vaccination rates, and the importance of an open dialogue between patients and clinicians, here.

Reported cases of chlamydia, syphilis, and gonorrhea in the US surpassed 2.5 million for the third time in 5 years, according to CDC.

Your daily dose of the clinical news you may have missed.

Parent's stigmatizing beliefs about the HPV vaccine may keep them from communicating openly with teens' clinicians, creating barriers to getting shots in arms.

Vaccine side effects are usually trouble when they make the news. But sometimes, an unexpected result has merit. Find out more.

Top-line data from the EVOGUARD clinical trial examining the efficacy of Phexxi for the prevention of chlamydia and gonorrhea are expected in October 2022.

New data showed a sharp drop in HIV tests administered in health care and non-health care settings from 2019 to 2020—primarily among persons disproportionately affected by HIV.

SAMPLE: Between 2019 and 2020, the rate of reported gonorrhea increased 10%. True or false? Plus, 6 more questions based on the CDC’s 2020 STD Surveillance Report.

Cases of gonorrhea, syphilis, and congenital syphilis in 2020 surpassed 2019 levels in the US, according to the CDC's 2020 STD Surveillance Report.

New study suggests HIV-1 infection is more virulent when transmitted through heterosexual penile-vaginal intercourse than through anal intercourse between men who have sex with men due to transmission bottlenecks.

The CDC update recommends that clinicians advise all sexually active patients about PrEP and includes a new section on prescribing injectable bimonthly cabotegravir.

California on Jan 1 became the first state to require insurance coverage for at-home testing for sexually transmitted infections; it isn't smooth sailing, yet.

The AAP updated its guidance to recommend routine HIV screening at least once in all adolescents aged ≥15 years and at-risk youth be rescreened annually.

Nearly 25% of patients with HIV who use antiretroviral therapy will reach 65 years of age or older by 2030, researchers projected in a new analysis.

The CDC released the first set of new STI guidelines since 2015. What are the notable updates that primary care physicians should know? Find out here.

Rates of reported STD cases in the US have reached an all-time high, again. Are you caught up on the latest CDC numbers? Try your hand at these 7 questions to find out.

SAMPLE: Approximately what percentage of the total US population had an STI at a given point in 2018? Plus 6 more questions on STI trends based on the latest CDC data.

Over 80% of college students surveyed said they were "likely" or "extremely likely" to use STI self-testing services if they could take it in the privacy of their own home.

Sexually distancing and declines in STD testing due to COVID-19 may have caused the recent decline in reported cases of syphilis, gonorrhea, and chlamydia in the US.

How much do you know about syphilis prevention, screening, and treatment? Test yourself with these 5 true or false questions.

How many young adults in the US actually receive their recommended doses of HPV vaccine? Take this 7-question quiz on a new report to learn more about the trends.

More young adults in the US are getting vaccinated against human papillomavirus, rising almost 50% in 5 years, according to a new report.

The underpinnings of the global HIV and STI epidemics are inextricable. A new report looks at combined solutions. We offer highlights.

Sexually transmitted infection cases have reached an all-time high at an alarming speed. Test your knowledge of different treatment options with our new case challenge. 

Take this brief test on the updated CDC guidelines to give yourself a refresher course in STD management and stay current with the latest practices.

If we had a vaccine that was as effective at reducing HIV infection as circumcision, it would be a recommended vaccine here in the US, argues this pediatrician.

Digital abnormalities; oral candidiasis and HIV-infection; extra dose of MMR; penile rash . . . here: a range of topics to challenge you.

Here: 5 things (at least) you may not know about human viral hepatitis.

Data from pivotal international phase III clinical trials showed superior efficacy, safety, and convenience for a new wave of direct-acting oral agents. The breakthrough will benefit physicians in all practice settings, including primary care.